scholarly journals Influence of an artificial pleural effusion technique on cardio-pulmonary function and autonomic activity

2007 ◽  
Vol 54 (1,2) ◽  
pp. 48-53 ◽  
Author(s):  
Hiroshi Fukuno ◽  
Katsuyoshi Tamaki ◽  
Mari Urata ◽  
Nao Kohno ◽  
Ichiro Shimizu ◽  
...  
Keyword(s):  
Pleural Effusion ◽  
Pulmonary Function ◽  
Autonomic Activity ◽  
Artificial Pleural Effusion

Shrinking lung syndrome in pediatric systemic lupus erythematosus

Lupus ◽  
2021 ◽  
pp. 096120332110103
Author(s):  
Alfonso Ragnar Torres Jimenez ◽  
Nayma Ruiz Vela ◽  
Adriana Ivonne Cespedes Cruz ◽  
Alejandra Velazquez Cruz ◽  
Alma Karina Bernardino Gonzalez
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Pleural Effusion ◽  
Pulmonary Function ◽  
Lupus Erythematosus ◽  
Pulmonary Function Tests ◽  
Age At Diagnosis ◽  
X Rays ◽  
Systemic Lupus ◽  
Function Tests ◽  
Restrictive Pattern

Shrinking Lung Syndrome (SLS) is a rare and little known complication associated with Systemic Lupus Erythematosus (SLE), characterized by progressive and unexplainable dyspnea, pleuritic pain, small pulmonary volumes and elevation of the diaphragm on chest X-rays as well as restrictive pattern on pulmonary function tests. Objective To describe clinical, radiological and treatment characteristics in pediatric patients with SLS. Material and methods This is a descriptive and retrospective study in patients under 16 years old with the diagnosis of SLE complicated by SLS at the General Hospital. National Medical Center La Raza. Clinical, radiological and treatment variables were analyzed. Results are shown in frequencies and percentages. Results Data from 11 patients, 9 females and 2 males were collected. Mean age at diagnosis of SLS was 12.2 years. Age at diagnosis of SLE was 11.1 years. SLEDAI 17.3. Renal desease 72%, hematological 91%, lymphopenia 63%, mucocutaneous 72%, neurological 9%, arthritis 54%, serositis 91%, fever 81%, secondary antiphospholipid syndrome, low C3 72%, low C4 81%, positive ANA 91%, positive anti-DNA 91%. Regarding clinical manifestations of SLE: cough 81%, dyspnea 91%, hipoxemia 81%, pleuritic pain 71%, average oxygen saturation 83%. Chest X-rays findings: right hemidiaphragm affection 18%, left 63%, bilateral 18%. Elevated hemidiaphragm 91%, atelectasis 18%, pleural effusion 91%, over one third of the cardiac silhouette under the diphragm 36%, bulging diaphragm 45%, 5th. anterior rib that crosses over the diaphragm 91%. M-mode ultrasound: diaphragmatic hypomotility 100%, pleural effusion 63%. Pulmonary function tests: restrictive pattern in 45% of the cases. Treatment was with supplementary oxygen 100%, intubation 18%, antibiotics 100%, steroids 100%, intravenous immunoglobulin 54%, plasmapheresis 18%, cyclophosphamide 54% and rituximab 18%. The clinical course was favorable in 81%. Conclusions SLS should be suspected in patients with SLE and active disease who present hipoxemia, pleuritic pain, cough, dyspnea, pleural effusion and signs of restriction on chest X-rays. Therefore, a diaphragmatic M-mode ultrasound should be performed in order to establish the diagnosis.

scholarly journals Effects of pneumothorax or pleural effusion on pulmonary function.

Thorax ◽  
1985 ◽  
Vol 40 (1) ◽  
pp. 60-65 ◽  
Author(s):  
J J Gilmartin ◽  
A J Wright ◽  
G J Gibson
Keyword(s):  
Pleural Effusion ◽  
Pulmonary Function

USEFULNESS THERAPY FOR HEPATOCELLULAR CARCINOMA LOCATED AT HEPATIC DOME: VALUE OF ARTIFICIAL PLEURAL EFFUSION

2003 ◽  
Vol 98 ◽  
pp. S85
Author(s):  
Naoki Hotta ◽  
Yoshitaka Fukuzawa ◽  
Akihiko Okumura ◽  
Tetsuya Ishikawa ◽  
Shinichi Kakumu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Pleural Effusion ◽  
Hepatic Dome ◽  
Artificial Pleural Effusion

A Study of Effect on Pulmonary Function of Pleural Effusion in Tuberculous pleurisy patients

1996 ◽  
Vol 43 (4) ◽  
pp. 491 ◽  
Author(s):  
Jeong Yoon Yim ◽  
Kee Hyun Lee ◽  
Hye Kyung Jung ◽  
Jung Hyun Chang ◽  
Seon Hee Cheon
Keyword(s):  
Pleural Effusion ◽  
Pulmonary Function ◽  
Tuberculous Pleurisy

Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome

2003 ◽  
Vol 38 (11) ◽  
pp. 1066-1070 ◽  
Author(s):  
Yasunori Minami ◽  
Masatoshi Kudo ◽  
Toshihiko Kawasaki ◽  
Hobyung Chung ◽  
Chikara Ogawa ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Pleural Effusion ◽  
Ultrasound Guided ◽  
Hepatic Dome ◽  
Artificial Pleural Effusion

scholarly journals Precise microwave ablation in hepatic neoplasms adjacent to high-risk structures: a prospective pilot study

2020 ◽  
Author(s):  
Liping Yang ◽  
Qinying Li ◽  
Gang Dong ◽  
Lulu Sun ◽  
Yan Xia ◽  
...  
Keyword(s):  
High Risk ◽  
Pleural Effusion ◽  
Preoperative Planning ◽  
3D Visualization ◽  
Serum Levels ◽  
Complete Separation ◽  
Planning System ◽  
Hepatic Neoplasms ◽  
Local Progression ◽  
Artificial Pleural Effusion

Abstract Objective To evaluate the safety and efficiency of ultrasound (US)-guided precise MWA assisted by artificial pleural effusion and/or ascites in hepatic neoplasms adjacent to high-risk structures based on a 3D preoperative planning system. Methods Twenty-five patients with hepatic neoplasms adjacent to high-risk structures were enrolled. CT images of all patients were reconstructed with 3D visualization software for preoperative planning. The puncture path and needle layout were estimated. US-guided precise MWA assisted by artificial pleural effusion and/or ascites was performed. Patients were followed by clinical and imaging examinations at 3, 6, and 12 months after the MWA. Study outcomes including complications, liver function, AFP level, and ablation lesion volumes were evaluated. Results Thirty-two tumors in 25 patients underwent precise MWA. Except for 4 patients with tumors near the macrovascular, 21 patients received artificial pleural effusion and/or ascites, achieving a complete separation. Based on preoperative 3D planning, patients with tumors near the diaphragmatic dome underwent administration of artificial pleural effusion and ascites, while patients with tumors near the gastrointestinal tract or gallbladder received artificial ascites. Of the 32 tumors, 30 achieved complete ablation in the first MWA session, and 29 achieved conformal ablation with a safe boundary of 0.5-1 cm. No severe complications were observed. Only one tumor exhibited local progression. Moreover, serum levels of ALT, AST and AFP were significantly decreased during the follow-up period. Conclusion Based on the 3D preoperative planning system, US-guided precise MWA assisted by artificial pleural effusion and ascites, is a safe and effective tool to treat hepatic neoplasms adjacent to high-risk structures.

Sign in / Sign up

Export Citation Format

Share Document